BLOG

Kimberly Worley shares her STEM journey, highlighting mentorship, diversity, and how empowering girls strengthens innovation and the future of science.

Grace Furman, President and CEO of Paracelsus, explores common misconceptions in IND-enabling toxicology programs and how sound regulatory toxicology supports safe, successful FIH trials.

We invited several of our Altascientists to share insights into their career journeys in the life sciences and their perspectives on the future of the field.

Ken Phares demystifies ICH Q14 & Q2(R2) guidelines with practical strategies for analytical procedure development, risk-based method design, and lifecycle management.

Discover how clinic-ready manufacturing and adaptive clinical trials streamline drug development, prevent delays, conserve your resources, and ensure safety, compliance, and efficiency.

The 2025 Year in Review highlights 30 years of drug development expertise, key milestones, events, resources, and innovations shaping early-phase research.

Brandon Ossont and Jennifer Lakritz share their first AALAS experiences, exploring scientific insights, networking, and professional growth in lab animal science.